Cholesterol gallstones are rare in childhood even in such populations as the Pima Indians who have a high prevalence of the disease.' Nevertheless, obesity predisposes to early appearance.2
In obese adults cholesterol gallstones exhibit a poor response to treatment with bile acids, since secretion of lithogenic bile persists even if high doses ofchenodeoxycholic acid (CDCA) are administered.3
Six adolescents under age 14 years have been referred to our outpatient clinic for treatment of symptomatic radiolucent gallstones during the last 3 years. Each was obese and had bile supersaturated with cholesterol.
Treatment with bile acids, CDCA, or ursodeoxycholic acid (UDCA) was successful, and the bile, initially lithogenic, became unsaturated with cholesterol, and gallstones disappeared or decreased in size between 6 and 12 months later.
Patients, methods, results
The clinical data for the patients are shown in Table 1 . In each case, gallstones were suspected on the basis of at least one episode of biliary colic and were diagnosed by cholecystography. Stone radiolucency was confirmed by plain x-ray films of the abdomen. Liver function tests, plasma cholesterol levels, and triglycerides were normal. Erythrocyte defects leading to increased haemolysis could be excluded by indices of erythrocytes, reticulocyte (Table 2) .
Both CDCA and UDCA became predominant in bile, whereas lithocholic acid did not show any major change during either treatment.
In order to assess the response in terms of stone dissolution, cholecystograms were repeated at 6-monthly intervals. Four patients showed complete dissolution; this was achieved by 3 patients at 6 months, and by the fourth at 12 months (Table 1) . Disappearance of stones was confirmed by ultrasonography and treatment was stopped 3 months later. The remaining two (Cases 4 and 6, Table 1) showed partial dissolution. Each had a single stone the diameter of which decreased from 12 to 7 mm and from 9 to 4 mm after 6 months. In Case 4, a further reduction in size to 3 mm was noted at 12 months. These 2 patients are still undergoing treatment.
UDCA was well tolerated, but diarrhoea and abdominal discomfort were experienced by 2 of the 3 patients who were given CDCA. Such symptoms Severe combined immunodeficiency (SCID) is a heterogeneous syndrome inherited either as an X-linked or an autosomal recessive disorder. Affected children lack both cell-mediated and humoral immunity; they present with repeated viral, bacterial, or fungal infections, have protracted diarrhoea, and failure to thrive.' Unless treated by bone marrow transplants the children generally die within the first year of life.
Most patients have an absolute deficiency of T-cell numbers with numbers of B-cells being absent, very low, or very high. Within families a similar pattern of T-and B-cell numbers is observed in affected individuals (personal experience of six families with more than one affected child). In 20 % of the autosomal recessive type, the disease is caused by a deficiency of adenosine deaminase, and in such families prenatal diagnosis demonstrates lack of the enzyme in amniotic cells.2 Prenatal diagnosis is not yet available for the remaining cases. However, the development of monoclonal antibodies which distinguish leucocyte populations, and in particular T-cell subsets, has enabled normal ranges to be established in healthy children and adults (unpublished) . Similarly, the diagnosis of various forms of immunodeficiency can be made by analysing lymphocyte phenotypes. We have recently developed a method for analysing the phenotype of leucocytes from very small samples of blood using monoclonal antibodies and a fluorescent activated cell sorter. Using this technique, normal ranges for leucocyte populations have been established in the second trimester of pregnancy on fetal blood samples (100-500 ,ul) obtained at fetoscopy for diagnosis of thalassaemia and haemophilia.3 It is therefore possible, if one knows the phenotype of a previously affected sibling, to offer prenatal advice to an at risk family during a second pregnancy.
Methods
Staining mononuclear cells. Venous blood specimens were obtained from 2 children with SCID in the first 2 days of life, and from 5 others below the age of 6 months. Mononuclear cells were obtained by Ficoll-Triosil centrifugation and after washing were stained with monoclonal mouse antisera (aliquots of cells at 2 x 105/ml) to human leucocyte subpopulations. The following antisera were used: (1) UCHT1 which recognises all mature T-cells.4 (2) Leu 3a which recognises helper/inducer T-cells.5 (3) Leu 2a which recognises suppressor/cytotoxic T-cells.5 (4) DA2 which recognises a non-polymorphic determinant of HLA Dr antigen.6 (5) OKMl which recognises cells of the monocytic series, some granulocytes, and cells with natural killer activity.7 (6) Anti Hle-1 which reactswith all peripheral blood leucocytes. 
